Employment Agreement



 Exhibit 10.1 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (the
“Agreement”) is made as of March 5, 2012, by and between Oleg Mikulinsky (the “Executive”), an individual, and Cryo-Cell International, Inc. (the “Company”), a Delaware corporation having its principal place of
business at 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, Florida 34677. 
 In consideration of the mutual covenants and
agreements contained herein and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
  

	1.	Employment 

 On the
terms and conditions set forth in this Agreement, the Company hereby employs the Executive for a period of twelve (12) months commencing on March 5, 2012, and expiring on March 4, 2013, (the “Initial Term”). The Initial Term
shall be automatically extended for successive additional one-year periods (“Additional Employment Terms”) unless, at least thirty (30) days prior to the end of the Initial Term or an Additional Employment Term the Company or the
Executive has notified the other in writing (“Termination Notice”) that the Agreement shall terminate at the end of the then current term. References herein to the “Term” shall mean the Initial Term as it may be so extended by
one or more Additional Employment Terms. 
 The Executive shall be employed as Chief Information Officer. The Executive shall
report directly to the Company’s Chief Executive Officer. 
 The Executive hereby accepts such employment and agrees to
devote his full business time, energy and efforts to the performance of services for the Company. The Executive agrees that during the Term, he shall devote his professional knowledge and experience and provide his best effort, skill and abilities
in the performance of his duties under this Agreement and in the furtherance of the interests of the businesses of the Company and its affiliates. 
  

	2.	Compensation 


During the Term, and as full compensation for all of the Executive’s services rendered under this Agreement, the Executive shall
receive the following compensation and benefits: 
  

	 	a.	Base Salary 

 Commencing
on March 5, 2012 the Executive shall receive an annualized base salary (the “Base Salary”) which is not less than $149,500 per year. Throughout the Term, the Executive shall be eligible for discretionary annual merit increases and/or
other base salary adjustments as deemed appropriate by the Company’s Chief Executive Officer. The Executive’s Base Salary will be payable in equivalent bi-weekly installments, subject to usual and required payroll deductions, including,
without limitation, applicable taxes. 
  

	 	b.	Annual Bonus 

 Throughout the Term, the Executive shall be eligible for discretionary annual lump-sum incentive awards available for senior executive officers based upon both personal and corporate performance for the
prior fiscal year. The annual bonus, if awarded, will be distributed on or about February 1st of each year of this Agreement based on performance for the previous fiscal year. The annual bonus is not guaranteed and its amount is subject to the discretion of the Compensation Committee. 









	 	c.	Employment Agreement Stock Options 

 In further consideration of this Agreement and for the Executive’s obligations hereunder, the Executive shall be awarded a stock option grant of 40,000 shares of Company stock as of the date this
Agreement is fully executed (the “Effective Date”), with a grant price equal to the fair market value of the Company’s stock on the Effective Date, and with vesting as follows: 

1/3 shall vest on the grant date; 
 1/3 shall vest on the first anniversary of the grant date; and 
 1/3 shall vest on
the second anniversary of the grant date. 
 In addition to the grant of stock options described above, if the Executive is
employed by the Company on March 4, 2014, then the Company shall grant the Executive stock options under the Company’s 2012 Stock Plan to acquire up to an additional 40,000 shares of Company stock for the achievement of the three criteria
described below for the fiscal year ending November 30, 2013 (up to 40,000 shares if all three Stretch criteria are achieved) with a grant price equal to the fair market value of a share of Company stock on March 5, 2012, with vesting for each
achieved Stretch criteria as follows: 
 1/3 shall vest on the grant date; 

1/3 shall vest on the first anniversary of the grant date; and 
 1/3 shall vest on the second anniversary of the grant date. 
  

					
	 FYE 11/30/13
	  	Stretch	 
	 Diluted revenue per share as of 11/30/13
	  	$	2.00	  
	 Diluted earnings per share as of 11/30/13
	  	$	0.33	  
	 Stock price as of 11/30/13
	  	$	7.50	  

  

	 	e.	Benefits 

 The Executive
shall be eligible for participation in the same welfare benefit plans, practices, policies and programs provided by the Company to senior executive officers of the Company, including but not limited to, health insurance, 401(k), medical, sick leave,
sick pay, holidays, long-term disability insurance and life insurance. The Executive shall be entitled to not less than three work weeks (15 work days) of paid vacation for each year of the Term, which vacation days shall accrue and become vested on
the first day of each year of the Term. 

  
 2 









	 	f.	Expenses 

 The Executive
shall be reimbursed for all reasonable business expenses incurred in the performance of his duties pursuant to this Agreement (including, without limitation, business travel related expenses) to the extent such expenses are substantiated and are
consistent with the general policies of the Company and its subsidiaries relating to the reimbursement of expenses of senior executive officers. 
  

	3.	Termination 

  

	 	a.	Termination by the Company for Cause 

 The Company shall have the right to terminate the Executive for Cause (as such term is hereinafter defined) at any time during this Agreement. For purposes of this Agreement, “Cause” means any
act or any failure to act on the part of the Executive which constitutes: (i) the willful and knowing or negligent failure or refusal of the Executive to perform his duties under this Agreement or to follow the reasonable directions of the
Company’s Chief Executive Officer; (ii) a breach by the Executive of his fiduciary duty to the Company; (iii) misfeasance or malfeasance by the Executive in connection with the performance of his duties under this Agreement that has a
demonstrably negative impact on the Company; (iv) the Executive’s commission of an act of fraud or embezzlement with regard to the Company; or (v) the conviction of the Executive for, or a plea of guilty or nolo contendere to a
criminal act which is a felony (other than as a result of vicarious liability or a routine traffic violation). 
 In the event
thereof, the Executive shall not be entitled to severance pay, or other compensation or benefits, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination pursuant to any applicable
benefit plan, earned but unused vacation for that year and unreimbursed business-related expenses in accordance with Company policy. Stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards granted to
Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 
  

	 	b.	Termination At or After Change in Control 

 In the event the Executive’s employment is terminated upon or within one (1) year after a Change in Control defined in subparagraph 3(c) below, or prior to the Change in Control if the
Executive’s termination, demotion or relocation was either a condition of the Change in Control or was at the request of any person related to the Change in Control, and such termination was initiated by the Company without cause or by the
Executive due to being requested to accept without cause a demotion or relocation: 
 (i) The Company shall pay to the Executive
any earned and accrued but unpaid installment of Base Salary through the date of termination, at the rate in effect on the date of termination, or if greater, on the date immediately preceding the date that a Change in Control occurs, and all other
unpaid amounts to which the Executive is entitled as of the date of termination under any compensation plan or program of the Company, including, without limitation, all accrued vacation time. Stock options, shares of restricted stock, performance
awards, stock appreciation rights, and LTI awards granted to Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. All outstanding stock options shall vest upon
termination. 

  
 3 








 (ii) In lieu of any further Base Salary, bonus payments and benefits to the Executive for
periods subsequent to the date of termination, the Company shall pay as liquidated damages to the Executive, an amount equal to twelve (12) months of the Executive’s annual Base Salary at the rate in effect as of the date of termination,
or if greater, on the date immediately preceding the date that a Change in Control occurs. 
  

	 	c.	Change in Control 

 For
the purposes of this Agreement, a Change in Control shall be deemed to occur when and if, during the Term: 
 (i) any person (as
such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any affiliate or associate as defined in Rule 12(b)-2 under the Exchange Act of such person, other than the
Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership
of stock of the Company) becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 30% or more of the combined voting power of the Company’s then
outstanding securities; 
 (ii) individuals who, as of the date hereof, constitute the Board (the “Incumbent Board”)
cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of
at least a majority of the directors then comprising the Incumbent Board shall be, for purposes of this Agreement, considered as though such person were a member of the Incumbent Board; 

(iii) the stockholders of the Company (A) approve a definitive agreement to merge or consolidate the Company with or into another
corporation or other enterprise in which the holders of outstanding stock of the Company entitled to vote in elections of directors immediately before such merger or consolidation hold less than 50% of the voting power of the survivor of such merger
or consolidation or its parent, or (B) approve a plan of liquidation; or 
 (iv) at least 80% of the Company’s assets
are sold or transferred to another corporation or other enterprise that is not a subsidiary, direct or indirect, or other affiliate of the Company. 
 (v) The Stockholders of the Company have approved a plan of a complete liquidation or dissolution of the Company. 
  

	 	d.	Termination by the Company Without Cause 

 In the event the Executive’s employment is terminated by the Company without Cause, other than as a result of a Change in Control as described in 3(b) and 3(c) or pursuant to a Termination Notice,
the Company shall pay to the Executive any earned and accrued but unpaid installment of Base Salary through the date of termination, at the rate in effect on the date of termination, and all other unpaid amounts to which the Executive is entitled as
of the date of termination under any compensation plan or program of the Company, including, without limitation, all accrued vacation time. Stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards
granted to Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 

  
 4 








 In lieu of any further Base Salary, bonus payments and benefits to the Executive for periods
subsequent to the date of termination, the Company shall pay as liquidated damages to the Executive, an amount equal to three (3) months of the Executive’s annual Base Salary at the rate in effect as of the date of termination. 

 

	 	e.	Expiration of the Term Pursuant to a Termination Notice by the Executive or the Company  


If the Executive’s employment with the Company terminates at the end of the Term pursuant to a Termination Notice by the Executive or
the Company, the Company shall have no further obligation to the Executive under this Agreement, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination, i.e. the end of the Term,
pursuant to any applicable benefit plan, earned but unused vacation for that year and unreimbursed business-related expenses in accordance with Company policy. Stock options, shares of restricted stock, performance awards, stock appreciation rights,
and LTI awards granted to Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 

 

	 	f.	Automatic Termination Due To Death or Disability 

 If the Executive dies or suffers any Disability (as defined below) his employment pursuant to this Agreement shall automatically terminate on the date of his death or Date of Disability (as defined
below), as the case may be. 
 The Company shall have no further obligation to the Executive or the Executive’s estate
under this Agreement, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination pursuant to any applicable benefit plan, earned but unused vacation for that year and unreimbursed
business-related expenses in accordance with Company policy. Stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards granted to Executive by the Company through the date of termination shall be
treated in accordance with the applicable plans and policies of the Company. 
 Termination of Executive’s employment based
on “Disability” shall be construed to comply with Code Section 409A and shall be deemed to have occurred if: (i) Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment that can be expected to result in death, or last for a continuous period of not less than 12 months; (ii) by reason of any medically determinable physical or mental impairment that can be expected to result in death, or
last for a continuous period of not less than 12 months, Executive is receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of the Company; or (iii) Executive is
determined to be totally disabled by the Social Security Administration. In the event of Executive’s Disability, the Company may terminate this Agreement, provided that the Company shall continue to be obligated to pay Executive his Base Salary
for six months, and provided further that any amounts actually paid to Executive pursuant to any disability insurance or other similar such program which the Company has provided or may provide on behalf of its


  
 5 








 
employees or pursuant to any workman’s or social security disability program shall reduce the compensation to be paid to Executive pursuant to this paragraph. Disability payments hereunder
shall commence within thirty (30) days of the Disability determination. 
  

	4.	Discoveries and Works 

 The Executive agrees that if at any time during the Term he, either independently or with others, makes, conceives, discovers, develops, or reduces to practice any invention, modification, discovery,
design, development, improvement, process, program, work of authorship, documentation, formula, data, technique, secret or intellectual property right whatsoever, including any television or film production, program, script or screen play, or any
interest therein (whether or not patentable or registrable under copyright or similar statutes or subject to analogous protection) (hereinafter referred to as “intellectual property rights”), not already in the public domain or previously
known by the Executive that (a) relates to the business of the Company or any affiliate of the Company, or any of the products or services being developed, manufactured, marketed or sold by the Company or any affiliate or which may be used in
relation therewith; (b) results from tasks assigned by the Company; or (c) results from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company or any affiliate, such
intellectual property rights shall become the sole and absolute property of the Company and its assigns. 
  

	5.	Confidentiality and Non-Competition Covenants 

  

	 	a.	Confidentiality 

 The
Executive acknowledges that, during the Term, the Executive may receive special training and/or may be given access to or may become acquainted with Confidential Information and Trade Secrets (as hereinafter defined) of the Company. As used in this
Section 5, “Confidential Information and Trade Secrets” of the Company means all trade practices, business plans, price lists, supplier lists, customer lists, marketing plans, financial information, software and all other compilations
of information which relate to the business of the Company, or to any of its affiliates, customers or suppliers, and which have not been disclosed by the Company to the public, or which are not otherwise generally available to the public.

 The Executive acknowledges that the Confidential Information and Trade Secrets of the Company, as such may exist from time to
time, are valuable, confidential, special and unique assets of the Company and its affiliates, expensive to produce and maintain and essential for the profitable operation of their respective businesses. The Executive agrees that, during the course
of his employment with the Company, or at any time thereafter, he shall not, directly or indirectly, communicate, disclose or divulge to any Person (as hereinafter defined), or use for his benefit or the benefit of any Person, in any manner, any
Confidential Information or Trade Secrets of the Company or its affiliates acquired during his employment with the Company or any other confidential information concerning the conduct and details of the businesses of the Company and its affiliates
except in the course of performing his duties hereunder or with the Company’s express written consent; provided, however, that the restrictions above shall not apply to that part of the Confidential Information and Trade Secrets that is or
becomes generally available to the public other than as a result of an improper disclosure by the Executive or is available, or becomes available, to the Executive on a non-confidential basis, but only if the source of such information is not to the
Executive’s knowledge prohibited from transmitting the information to the Executive by a contractual, legal, fiduciary, or other obligation or that the Executive is required to disclose such Confidential Information and Trade Secrets by
applicable law, regulation or legal process. 

  
 6 








 All documents relating to the businesses of the Company and its affiliates including,
without limitation, Confidential Information and Trade Secrets of the Company, whether prepared by the Executive or otherwise coming into the Executive’s possession, are the exclusive property of the Company and such respective affiliates, and
must not be removed from the premises of the Company, except as required in the course of the Executive’s employment with the Company. The Executive shall return all such documents (including any copies thereof) to the Company when the
Executive ceases to be employed by the Company, provided the Company requests so in writing anytime during the Term of this Agreement and/or any Additional Employment Term or five (5) days after the termination of this Agreement or upon the
earlier request of the Company or the Board. 
  

	 	b.	Non-Competition 

 During
the Term and for a period of twelve (12) months following the termination of the Executive’s employment under this Agreement for any reason other than disability or death, the Executive shall not, except with the Company’s express
prior written consent or in the proper course of his employment with the Company, directly or indirectly, in any capacity, for the benefit of any Person (including the Executive): 

(i) Become employed by, own, operate, manage, direct, invest in, or otherwise, directly or indirectly, engage in, or be employed by any
Person, which is a Direct Competitor (as defined below) of the Company, its affiliates, or any of its respective businesses; provided the foregoing does not apply to an affiliate of such Direct Competitor which does not itself compete with the
Company and, in connection therewith the Executive may own equity in such non-competing affiliates. 
 (ii) Solicit, service,
divert, take away, or contact any customer or client of the Company, or any of its affiliates, to provide or promote services then provided by the Company, or any of its affiliates cord blood preservation and/or storage facility industry.

 (iii) Induce or attempt to induce any employee of the Company or its subsidiaries to stop working for the Company, or any of
its affiliates, or to work for any competitor of the Company, or any of its affiliates; provided that the foregoing shall not be violated by general advertising not targeted at Company employees nor by serving as a reference for an employee with
regard to an entity with which the Executive is not affiliated. 
  

	 	c.	Definitions of Person and Direct Competitor 

 For purposes of this Agreement, the term “Person” means any individual (except the Executive’s Assistant at the time of his termination), partnership, corporation, trust and/or any other
entity of any nature whatsoever. A “Direct Competitor” means any Person that operates or manages a cord blood preservation and/or storage facility (either existing as of the date of this Agreement or created or launched during the Term in
the territories in which the Company operated during the Term. However, “Direct Competitor” shall not mean any Person that operates or manages a Public Cord Blood Bank. A “Public Cord Blood Bank” means a cord blood preservation
and/or storage facility which accepts cord blood donations to be used by anyone in need of said cord blood. 

  
 7 









	6.	Reliance 

 The
Executive acknowledges that his compliance with the provisions of Section 5 of this Agreement (hereinafter referred to as the “Restrictive Covenants’) is a material part of the consideration bargained for by the Company under this
Agreement. The Executive agrees to be bound by the provisions of Section 5 of this Agreement to the maximum extent permitted by law, it being the intent and spirit of the parties to this Agreement that the provisions of Section 5 of this
Agreement shall be enforceable. However, the parties to this Agreement further agree that if any portion of the Restrictive Covenants or their application is construed to be invalid or unenforceable, then the other portions thereof and their
application shall not be affected thereby and shall be enforceable. If the Restrictive Covenants shall for any reason be held to be excessively broad as to duration, geographic scope, property, subject or similar factor, then the court making such
determination shall have the power to reduce or limit such duration, geographic scope, property, subject or similar factors so as to be enforceable to the maximum extent compatible with applicable law, and the Restrictive Covenants shall then be
enforceable in its reduced or limited form. 
  

	7.	Equitable Relief and Enforcement 

 The Executive further acknowledges that any breach by him of the Restrictive Covenants will result in irreparable injury to the Company and its affiliates for which money damages could not adequately
compensate the Company or such affiliates. In the event of any such breach, the Company shall be entitled, in addition to all other rights and remedies which it may have at law or in equity, to have an injunction issued by any competent court
enjoining and restraining the Executive from continuing such breach. 
  

	8.	Indemnification 


The Company hereby agrees to indemnify the Executive and hold him harmless to the fullest extent permitted by applicable law against and
in respect to any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses (including reasonable attorney’s fees), losses, and damages resulting from the Executive’s good faith performance of his duties and
obligations with the Company. This provision is in addition to any other rights of indemnification the Executive may have. This provision shall in all events survive any termination of this Agreement. 

 

	9.	Liability Insurance 


The Company shall cover the Executive under directors’ and officers’ liability insurance both during and, while potential
liability exists, after the Term in the same amount and to the same extent as the Company covers its other senior executive officers and directors. This provision shall in all events survive any termination of this Agreement. 

 

	10.	Miscellaneous 

  

	 	a.	Entire Agreement 

 This
Agreement constitutes the entire agreement between the parties to this Agreement with respect to the subject matter of this Agreement and supersedes all prior negotiations, understandings, agreements, arrangements and understandings, both oral and
written, between 

  
 8 








 
the parties to this Agreement with respect to the Executive’s employment during the Term. This Agreement shall not be construed as affecting in any way the shares of restricted stock,
performance awards, stock appreciation rights and stock options provided to the Executive by the Company prior to the date of this Agreement other than as expressly provided herein. 

 

	 	b.	Amendment; Waivers; Headings 

 This Agreement may not be amended or modified in any respect, except by the mutual written agreement of the parties to this Agreement. The waiver by any of the parties to this Agreement of any other
party’s prompt and complete performance, or breach or violation, of any of the provisions of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation, and the waiver by any of the parties to this
Agreement to exercise any right or remedy which it may possess under this Agreement shall not operate nor be construed as a bar to the exercise of such right or remedy by such party upon the occurrence of any subsequent breach or violation.
Descriptive headings contained in this Agreement are for convenience only and shall not control or affect the meaning or construction of any provision of this Agreement. Notwithstanding anything in this Agreement to the contrary, the provisions of
Sections 4, 5, 6, 7, 8 and 9 of this Agreement shall survive the termination of the Executive’s employment under this Agreement, however caused, and the termination of this Agreement. 

 

	 	c.	Counterparts 

 This
Agreement may be executed in any number of counterparts and by the separate Parties hereto in separate counterparts, each of which shall be deemed to be one and the same instrument. 

 

	 	d.	Notices 

 All notices,
requests, demands, instructions, consents or other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been duly given if and when (a) delivered personally, (b) transmitted
by facsimile, prepaid telegram or telex, (c) mailed by first class certified mail, return receipt requested, postage prepaid, or (d) sent by an internationally recognized express courier service, postage or delivery charges prepaid, to the
Parties at their respective addresses set forth in the first paragraph of this Agreement or to such other addresses as the parties may give notice in accordance with the terms of this Agreement. 

 

	 	e.	Successors and Assigns 


This Agreement shall be binding upon and shall inure to the benefit of the Parties to this Agreement and their respective personal
representatives, heirs, successors and assigns. 
  

	 	f.	Applicable Law; Arbitration as Exclusive Remedy 

 This Agreement shall be governed by and construed in accordance with the laws of the State of Florida. All controversies or claims arising out of or relating to paragraph I through 3 of this Agreement or
the breach thereof, or the termination thereof, shall be resolved by arbitration administered by the American Arbitration Association under its National Rules for the Resolution of Employment Disputes. The award rendered in any arbitration
proceeding under this section shall be final and binding. Judgment upon the award 

  
 9 








 
rendered by the arbitrator(s) may be entered by a court of competent jurisdiction. Any claim or controversy not submitted to arbitration in accordance with this section shall be considered
waived, and, therefore, no arbitration panel or tribunal or court shall have the power to rule or make any award on such claims or controversy. Any such arbitration shall be conducted in Tampa, Florida. The prevailing party in such arbitration
proceeding shall be entitled to recover reasonable expenses, including attorneys fees and costs. 
 The parties agree to submit
all controversies or claims arising out of or relating to paragraphs 4 through 7 to the exclusive jurisdiction of the courts of the State of Florida. The parties further agree that the only and proper venue for any action upon any alleged breach of
any provision or obligation under this Agreement shall be Hillsborough County, Florida. 
 IN WITNESS WHEREOF, the parties to
this Agreement have placed their hands as of the day and year first above written. 
  

									
	 	 	 	 	 	 	Cryo-Cell International, Inc.
				
	 /s/ Oleg Mikulinsky
	 		 	By:	 	 /s/ David Portnoy

	Oleg Mikulinsky	 		 	Name:	 	David Portnoy
		 		 		 	Title:	 	Co-Chief Executive Officer
					
	Date:	 	 March 5, 2012
	 		 	Date:	 	 March 5, 2012



  
 10